Novo, Lilly Obesity Drug Labels To Shed Suicidal Ideation Warnings

 
• By Sue Sutter
  
Cutting caution tape
The FDA wants to cut suicidal ideation warnings out of labeling for GLP-1s approved for obesity. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Drug Safety

More from United States